Today on THCB Spotlights, Matthew sits down with Paul Johnson, the CEO of Lemonaid. Lemonaid just closed a $33 million Series B led by Olive Tree Ventures, expanding their direct-to-consumer online services which provide primary care visits as well as pharmacy and medication delivery to your home and launching into more chronic areas of care, such as hypertension, high cholesterol, asthma and type 2 diabetes. Why did they wind up with an Israel-focused lead investor in Olive Tree as a San Francisco-based company? Where is Lemonaid in terms of growth and revenue? And how is Lemonaid differentiating itself against some of the other chronic care management and telehealth companies? Find out how the company aims to provide care for patients holistically and be the first point of contact for patients in seeking healthcare.



from The Health Care Blog https://ift.tt/30e43PG

Related Posts:

  • Why Primary Care Should Run the Healthcare SystemBy KEN TERRY (This is the fourth in a series of excerpts from Terry’s new book, Physician-Led Healthcare Reform: a New Approach to Medicare for All, published by the American Association for Physician Leadership.) Many oth… Read More
  • A New Kind of Labor Day By KIM BELLARD This is probably the strangest Labor Day in decades, perhaps ever.   Tens of millions of workers remain unemployed due to the COVID-19 pandemic.  Many of those who are still working are adapti… Read More
  • To Avoid Pay Cuts, Doctors Must Reduce Waste By KEN TERRY (This is the fifth in a series of excerpts from Terry’s new book, Physician-Led Healthcare Reform: a New Approach to Medicare for All, published by the American Association for Physician Leadership.) Real heal… Read More
  • The Medical AI Floodgates Open, at a Cost of $1000 per Patient By LUKE OAKDEN-RAYNER In surprising news this week, CMS (the Centres for Medicare & Medicaid Services) in the USA approved the first reimbursement for AI augmented medical care. Viz.ai have a deep learning model which … Read More
  • #COVID19 Symptom Data ChallengeBy FARZAD MOSTASHARI & INDU SUBAIYA Applications for the #COVID19 Symptom Data Challenge close in three weeks!  Amidst #COVID19, using analytic approaches to maximize available information and data is paramount. H… Read More

0 comments:

Post a Comment

Popular Posts